Skip to main content
. Author manuscript; available in PMC: 2007 Aug 21.
Published in final edited form as: Int J Cancer. 2006 Mar 1;118(5):1234–1240. doi: 10.1002/ijc.21474

TABLE II.

MEDIAN TOTAL PSA, FREE PSA, AND HK2 LEVELS OF PROSTATE CANCER PATIENTS, AMONG THE WHOLE COHORT AND AMONG PATIENTS WITH PSA ≤ 10 ng/ml

Biomarker Median
All patients (n = 461)
  tPSA 8.09 (5.59–12.55)a
  fPSA 0.95 (0.64–1.42)
  hK2 0.091 (0.054–0.130)
 tPSA ≤ 10 ng/ml (n = 294)
  tPSA 6.4 (4.7–7.9)
  fPSA 0.75 (0.53–1.08)
  hK2 0.070 (0.045–0.100)
a

Values in parentheses indicate interquartile range in ng/ml.